CTO navigation innovation
This article was originally published in The Gray Sheet
Stereotaxis announces agreement Oct. 18 with Baylis Medical to develop and commercialize a magnetically steerable radio frequency (RF) guidewire to cross both coronary and peripheral chronic total occlusions. The collaboration combines Stereotaxis' Niobe magnetic navigation system and Baylis' RF energy delivery system to facilitate maneuverability through fully occluded vessels. CTO devices have battled technical and financial headwinds entering the market (1"The Gray Sheet" March 6, 2006, p. 13)...
You may also be interested in...
Despite recent advances in specialized guidewires, industry has struggled to develop effective new technologies to aid in opening coronary chronic total occlusions, according to interventionalists
The Pink Sheet explains the procedures underpinning the UK’s emergency use authorization of the Pfizer/BioNTech COVID-19 vaccine.
The US Food and Drug Administration posted two device-related closeout letters in November.